26 September 2022
Foley Represents TCG Crossover as Lead Investor in EUR 49.2M Crossover Financing for Abivax
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Louis Lehot Lead | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Andy Rawlins | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Raj Tanden | Foley & Lardner LLP | Partner | Not stated | Not stated |
| Ashley Lee | Foley & Lardner LLP | Associate | Not stated | Not stated |
| Stephen Moore | Foley & Lardner LLP | Associate | Not stated | Not stated |
| Laurent Beauvoit | Lexelians | Not stated | Not stated | Paris |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 49.2m (EUR 49.2 million)
- What the figure measures
- Total transaction value
- Client
- TCG CrossoverInvestor
- Counterparties
- Abivax (Issuer)
Venrock Healthcare Capital Partners (Investor)
Deep Track Capital (Investor)
Sofinnova Partners (Investor)
Invus (Investor)
Truffle Capital (Investor)